Best Transarterial Radioembolization- TARE Hospitals in Singapore

Choosing Mount Elizabeth Novena Hospital for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 2012, the JCI hospital in Novena, Singapore has 313 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.

Mount Elizabeth Hospital provides specialised Transarterial Radioembolization- TARE with a focus on precision, patient safety, and individualised cancer treatment. Established in 1979, the JCI hospital is located in Singapore, Singapore, and operates 345 beds, equipped with modern healthcare infrastructure.

Transarterial Radioembolization (TARE) is a form of locoregional radiation therapy designed to target tumors within the liver while reducing radiation exposure to healthy tissue. It is commonly used for selected primary liver cancers and metastatic tumors involving the liver. The treatment typically involves catheter-based delivery of radioactive microspheres into the tumor's arterial blood supply. Comprehensive evaluation before treatment and follow-up imaging afterwards help doctors assess suitability, treatment response, and liver health.

At Gleneagles Hospital, Transarterial Radioembolization- TARE is performed using advanced image-guided techniques and personalised treatment plans based on the patient's condition. Established in 1959, this JCI hospital in Singapore, Singapore has 258 beds and provides comprehensive cancer care.

Transarterial Radioembolization (TARE) may be considered for patients with selected liver tumors, including hepatocellular carcinoma and certain metastatic cancers. The procedure involves guiding a catheter through the blood vessels to the liver and delivering radioactive microspheres directly into the arteries supplying the tumor. Patients usually undergo imaging and laboratory assessments before treatment to evaluate liver function and vascular anatomy. Follow-up care and imaging are used to monitor response and manage potential side effects.

Parkway East Hospital is a trusted healthcare provider for Transarterial Radioembolization- TARE, offering advanced interventional oncology services supported by experienced specialists and modern medical infrastructure. Established in 1942, the JCI hospital is situated in Singapore, Singapore and has 143 beds.

Transarterial Radioembolization (TARE) is a targeted treatment that delivers radiation directly to tumors in the liver through the hepatic arterial blood supply. It may be used when surgery or other treatments are not suitable or as part of a broader treatment strategy, depending on the patient's condition. Before the procedure, specialists assess the tumor and liver using imaging and other diagnostic tests. Regular follow-up helps evaluate tumor response and liver function.

Choosing Thomson Medical Centre for Transarterial Radioembolization- TARE gives patients access to experienced interventional radiologists, advanced imaging technology, and multidisciplinary cancer care. Established in 1979, the hospital in Singapore, Singapore has 190 beds and provides specialised healthcare services.

Transarterial Radioembolization (TARE) is a minimally invasive procedure used to treat selected tumors located in the liver. During treatment, radioactive microspheres are delivered through a catheter into blood vessels supplying the tumor. The microspheres become lodged in the tumor's blood supply and release radiation over time. Patient selection generally involves detailed imaging, blood tests, and assessment of liver function before treatment, followed by monitoring and follow-up imaging.